Key facts
- It has raised $11.5M across 1 recorded rounds; the latest was Early Stage VC ($6.8M) in Nov 2024.
- Longevity Medical Institute has filed 4 Form Ds with the SEC, most recently Dec 2025 ( sold).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Longevity Medical Institute
Funding rounds
1 roundsAbout Longevity Medical Institute
Provider of clinical services intended for regenerative and preventive care purposes. The company offers physician-supervised programs that include cell-based therapies, diagnostic evaluations, infusion treatments, and rehabilitation procedures, enabling individuals seeking medical support or wellness monitoring to access structured assessments, targeted interventions, and integrated treatment plans that address functional concerns, age-related changes, and general health management.
- Sector
- Healthcare
- HQ
- Houston, TX, United States
- Founded
- 2024
- Website
- longevity-institute.com/
- Ownership
- Privately Held (backing)
Longevity Medical Institute doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Longevity Medical Institute shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Longevity Medical Institute in its N-PORT filings yet. We sweep new filings monthly.